CATALOGO DEI PRODOTTI DELLA RICERCA

BRONTE, Vincenzo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 9.088
NA - Nord America 8.685
AS - Asia 5.738
SA - Sud America 885
AF - Africa 106
OC - Oceania 28
Continente sconosciuto - Info sul continente non disponibili 5
Totale 24.535
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.563
GB - Regno Unito 2.871
RU - Federazione Russa 2.570
SG - Singapore 2.349
CN - Cina 1.778
IT - Italia 774
HK - Hong Kong 746
BR - Brasile 728
DE - Germania 611
FI - Finlandia 529
FR - Francia 527
IE - Irlanda 439
SE - Svezia 350
VN - Vietnam 285
KR - Corea 197
UA - Ucraina 139
NL - Olanda 78
TR - Turchia 67
CA - Canada 66
IN - India 64
AR - Argentina 62
ID - Indonesia 61
JP - Giappone 42
AT - Austria 36
ZA - Sudafrica 36
ES - Italia 34
MX - Messico 33
BE - Belgio 30
EC - Ecuador 29
BD - Bangladesh 27
PL - Polonia 25
AU - Australia 19
CO - Colombia 19
PK - Pakistan 14
MA - Marocco 13
IQ - Iraq 12
PY - Paraguay 12
CZ - Repubblica Ceca 11
EG - Egitto 10
PE - Perù 10
SA - Arabia Saudita 9
TG - Togo 9
VE - Venezuela 9
AL - Albania 8
BJ - Benin 8
KE - Kenya 8
NZ - Nuova Zelanda 8
UZ - Uzbekistan 8
AZ - Azerbaigian 7
CL - Cile 7
TN - Tunisia 7
AE - Emirati Arabi Uniti 6
OM - Oman 6
TW - Taiwan 6
BY - Bielorussia 5
CR - Costa Rica 5
IL - Israele 5
IR - Iran 5
JM - Giamaica 5
LT - Lituania 5
LV - Lettonia 5
MY - Malesia 5
PH - Filippine 5
AM - Armenia 4
BO - Bolivia 4
DK - Danimarca 4
HU - Ungheria 4
NP - Nepal 4
RO - Romania 4
BA - Bosnia-Erzegovina 3
CH - Svizzera 3
EE - Estonia 3
JO - Giordania 3
KG - Kirghizistan 3
LA - Repubblica Popolare Democratica del Laos 3
LU - Lussemburgo 3
MK - Macedonia 3
NG - Nigeria 3
SK - Slovacchia (Repubblica Slovacca) 3
UY - Uruguay 3
AD - Andorra 2
AO - Angola 2
BG - Bulgaria 2
BH - Bahrain 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
ET - Etiopia 2
EU - Europa 2
HN - Honduras 2
LB - Libano 2
LK - Sri Lanka 2
PA - Panama 2
PS - Palestinian Territory 2
SI - Slovenia 2
SO - Somalia 2
TH - Thailandia 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BN - Brunei Darussalam 1
CG - Congo 1
Totale 24.511
Salva come PNG Salva come JPEG
Città #
Southend 2.673
Jacksonville 1.243
Singapore 925
Chandler 857
Woodbridge 851
Moscow 793
Hong Kong 733
Dallas 721
Ann Arbor 635
Ashburn 583
Houston 440
Dublin 427
Verona 376
Beijing 297
Lawrence 220
Princeton 220
Wilmington 218
Los Angeles 186
Munich 171
New York 151
Helsinki 134
Nanjing 132
The Dalles 129
Shenyang 119
Jinan 115
Buffalo 96
Sindelfingen 84
Ho Chi Minh City 83
Columbus 80
Redmond 75
Tianjin 75
Redondo Beach 67
Hebei 66
Milan 65
São Paulo 58
Nanchang 55
Haikou 51
Ningbo 49
Hangzhou 48
Hanoi 48
San Francisco 48
Zhengzhou 47
Changsha 44
Jakarta 42
Santa Clara 42
Guangzhou 39
Seattle 38
Chicago 35
Jiaxing 35
Taizhou 34
Tokyo 33
Turku 32
Norwalk 31
London 30
Brooklyn 29
Brussels 29
Seoul 29
Nuremberg 28
Toronto 28
Dong Ket 27
Council Bluffs 26
Boardman 25
Phoenix 25
Stockholm 25
Taiyuan 25
Amsterdam 24
Johannesburg 22
Redwood City 22
Rio de Janeiro 22
Dearborn 20
Dongguan 20
Fuzhou 20
Falls Church 19
Vienna 19
Boston 18
Brasília 18
Warsaw 18
Washington 18
Belo Horizonte 16
Denver 16
Frankfurt am Main 16
Atlanta 15
Grafing 15
Montreal 15
Chennai 14
Lappeenranta 14
Fairfield 13
Haiphong 13
Orem 13
Quito 13
Ankara 12
Falkenstein 12
Düsseldorf 11
Lanzhou 11
Campinas 10
Da Nang 10
Padova 10
Ribeirão Preto 10
San Diego 10
St Petersburg 10
Totale 15.714
Salva come PNG Salva come JPEG
Nome #
IFN-gamma- Mediated Upmodulation of MHC Class I Expression Activates Tumor-Specific Immune Response in a Mouse Model of Prostate Cancer 262
Immune checkpoint blockade therapy mitigates systemic inflammation and affects cellular FLIP-expressing monocytic myeloid-derived suppressor cells in non-progressor non-small cell lung cancer patients 261
MAP Kinase inhibition reshapes tumour microenvironment of mouse pancreatic cancer by depleting anti-inflammatory macrophages 244
IFN-gamma- Mediated Upmodulation of MHC Class I Expression Associated to a B7-1-Expressing Tumor Cell Vaccine Activates Tumor-Specific Immune Response in a Mouse Model of Prostate Cancer. 239
Autologous cellular vaccine overcomes cancer immunoediting in a mouse model of myeloma 215
Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3 213
CD66b-CD64dimCD115- cells in the human bone marrow represent neutrophil-committed progenitors 210
Deciphering the state of immune silence in fatal COVID-19 patients 199
Unraveling the role of lymph node metastasis in PDAC and dCCA progression 193
Autoimmune B-cell lymphopenia after successful adoptive therapy with telomerase-specific T lymphocytes. 188
Apoptotic death of CD8+ T lymphocytes after immunization: induction of a suppressive population of Mac-1+/Gr-1+ cells. 186
Effective control of acute myeloid leukaemia and acute lymphoblastic leukaemia progression by telomerase specific adoptive T-cell therapy 186
Feasibility of telomerase-specific adoptive T-cell therapy for B-cell chronic lymphocytic leukemia and solid malignancies 184
Prostate-specific membrane antigen (PSMA) assembles a macromolecular complex regulating growth and survival of prostate cancer cells "in vitro" and correlating with progression "in vivo" 181
Baricitinib restrains the immune dysregulation in patients with severe COVID-19 181
Magnitude of PD-1, PD-L1 and T Lymphocyte Expression on Tissue from Castration-Resistant Prostate Adenocarcinoma: An Exploratory Analysis 180
IFN-gamma-mediated upmodulation of MHC class I expression activates tumor-specific immune response in a mouse model of prostate cancer 176
Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers 174
Immunoevolution of mouse pancreatic organoid isografts from preinvasive to metastatic disease 172
Antigen specificity of immune suppression by myeloid-derived suppressor cells. 167
Altered macrophage differentiation and immune dysfunction in tumor development. 165
Disabled homolog 2 controls pro-metastatic activity of tumor-associated macrophages 162
Antitumour efficacy of lymphokine-activated killer cells loaded with ricin against experimentally induced lung metastases. 161
Antigen expression by dendritic cells correlates with the therapeutic effectiveness of a model recombinant poxvirus tumor vaccine. 159
Adoptive immunotherapy of experimental tumors using cytotoxic lymphocytes to carry and deliver toxins 156
Human Anti Cancer Cytokine Induced Killer Cells and TheirInteraction With the Host Immune System 156
Induction of immunosuppressive functions and NF-κB by FLIP in monocytes 156
Fatal cytokine release syndrome by an aberrant FLIP/STAT3 axis 155
A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-kappaB and enhanced IRF-3/STAT1 activation). 154
Antitumor vaccination: where we stand. 153
Adoptive transfer of lymphokine-activated killer cells loaded with 4'-deoxy-4'-iododoxorubicin: therapeutic effect in mice bearing lung metastases. 153
Activated T cells sustain myeloid-derived suppressor cell-mediated immune suppression 153
Active immunotherapy of cancer with a nonreplicating recombinant fowlpox virus encoding a model tumor-associated antigen. 152
A human promyelocytic-like population is responsible for the immune suppression mediated by myeloid-derived suppressor cells. 151
Role of P2z purinergic receptors in ATP-mediated killing of tumor necrosis factor (TNF)-sensitive and TNF-resistant L929 fibroblasts. 151
The immune modulatory effects of umbilical cord-derived mesenchymal stromal cells in severe COVID-19 pneumonia 146
Interrupting the nitrosative stress fuels tumor-specific cytotoxic T lymphocytes in pancreatic cancer 146
The Emerging Immunological Role of Post-Translational Modifications by Reactive Nitrogen Species in Cancer Microenvironment 144
A Relay Pathway between Arginine and Tryptophan Metabolism Confers Immunosuppressive Properties on Dendritic Cells 144
MDSCs in cancer: Conceiving new prognostic and therapeutic targets 143
Axon guidance cue SEMA3A promotes the aggressive phenotype of basal-like PDAC 142
Anti-tumor activity of cytotoxic T lymphocytes elicited with recombinant and synthetic forms of a model tumor-associated antigen. 142
4PD Functionalized Dendrimers: A Flexible Tool for In Vivo Gene Silencing of Tumor-Educated Myeloid Cells 142
Anatomically restricted synergistic antiviral activities of innate and adaptive immune cells in the skin. 141
mTOR and STAT3 Pathway Hyper-Activation is Associated with evated Interleukin-6 Levels in Patients with Shwachman-Diamond Syndrome: Further Evidence of Lymphoid Lineage Impairment 140
The Endless Saga of Monocyte Diversity 139
Platelets promote thromboinflammation in SARS-CoV-2 pneumonia 137
Activation of p53 in Immature Myeloid Precursor Cells Controls Differentiation into Ly6c+CD103+Monocytic Antigen-Presenting Cells in Tumors 135
Detection and functional evaluation of arginase-1 isolated from human PMNs and murine MDSC 132
Neutralization of NET-associated human ARG1 enhances cancer immunotherapy 130
Chemokine nitration prevents intratumoral infiltration of antigen-specific T cells. 130
Characterization of Myeloid-derived Suppressor Cells in a Patient With Lung Adenocarcinoma Undergoing Durvalumab Treatment: A Case Report 130
Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factor. 128
Anti-L-selectin monoclonal antibody treatment in mice enhances tumor growth by preventing CTL sensitization in peripheral lymph nodes draining the tumor area. 128
Transcription factors in myeloid-derived suppressor cell recruitment and function. 127
Adipocytes and Neutrophils Give a Helping Hand to Pancreatic Cancers 126
New idrosoluble furoxan derivatives having antitumoral activity 124
Nitric oxide furoxan derivative compounds endowed with antitumoral activity 124
The cross-talk between myeloid and mesenchymal stem cells of human bone marrow represents a biomarker of aging that regulates immune response and bone reabsorption 122
Interfacing polymeric scaffolds with primary pancreatic ductal adenocarcinoma cells to develop 3D cancer models. 121
Therapeutic antitumor response after immunization with a recombinant adenovirus encoding a model tumor-associated antigen. 120
Tumor-induced myeloid deviation: when myeloid-derived suppressor cells meet tumor-associated macrophages 120
PDE5 INHIBITOR COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY 119
Interleukin-10 enhances the therapeutic effectiveness of a recombinant poxvirus-based vaccine in an experimental murine tumor model. 116
IL-12 is an effective adjuvant to recombinant vaccinia virus-based tumor vaccines: enhancement by simultaneous B7-1 expression. 116
Identification of a CD11b(+)/Gr-1(+)/CD31(+) myeloid progenitor capable of activating or suppressing CD8(+) T cells. 116
Therapeutic targeting of myeloid-derived suppressor cells. 115
Unopposed production of granulocyte-macrophage colony-stimulating factor by tumors inhibits CD8+ T cell responses by dysregulating antigen-presenting cell maturation. 115
Myeloid-derived suppressor cell heterogeneity in human cancers 115
IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing mice. 114
Expression of the membrane tetraspanin claudin 18 on cancer cells promotes T lymphocyte infiltration and antitumor immunity in pancreatic cancer 113
IL4Ralpha+ myeloid-derived suppressor cell expansion in cancer patients. 112
GCN2 drives macrophage and MDSC function and immunosuppression in the tumor microenvironment 112
Preventive vaccination with telomerase controls tumor growth in genetically engineered and carcinogen-induced mouse models of cancer. 110
Derangement of immune responses by myeloid suppressor cells. 110
Costimulation enhances the active immunotherapy effect of recombinant anticancer vaccines. 110
Immune tolerance to tumor antigens occurs in a specialized environment of the spleen. 110
Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF. 110
Use of myeloid cell biomarkers for the diagnosis of cancer. 109
Responses of mouse lymphocytes to extracellular ATP. II. Extracellular ATP causes cell type-dependent lysis and DNA fragmentation. 108
Meccanismi molecolari della lisi mediata dai linfociti citotossici 108
Local ablation disrupts immune evasion in pancreatic cancer 107
Role of arginine metabolism in immunity and immunopathology. 107
Interaction of human pancreatic ductal adenocarcinoma cells with polymeric scaffolds to develop tissue-engineered cancer models. 106
Gene expression profiling of human fibrocytic myeloid-derived suppressor cells (f-MDSCs) 105
Myeloid-derived suppressor cells generated in vitro 105
Smoothing T cell roads to the tumor: Chemokine post-translational regulation. 105
Peripheral blood immunophenotyping in a large cohort of patients with Shwachman-Diamond syndrome 105
In vivo administration of artificial antigen-presenting cells activates low-avidity T cells for treatment of cancer. 104
Low dose gemcitabine-loaded lipid nanocapsules target monocytic myeloid-derived suppressor cells and potentiate cancer immunotherapy 104
Nicotinamide Phosphoribosyltransferase Acts as a Metabolic Gate for Mobilization of Myeloid-Derived Suppressor Cells 104
Immunocompromised tumor-bearing mice show a selective loss of STAT5a/b expression in T and B lymphocytes. 103
Human fibrocytic myeloid-derived suppressor cells express IDO and promote tolerance via Treg-cell expansion 102
Myeloid suppressor lines inhibit T cell responses by an NO-dependent mechanism. 102
Role of adhesion molecules in the immune reaction to M-MSV-induced tumors. 102
Resistance of lymphokine-activated T lymphocytes to cell-mediated cytotoxicity. 102
Cancer Immune Modulation and Immunosuppressive Cells: Current and Future Therapeutic ApproachesNano-Oncologicals 102
Plasmacytoid Dendritic Cell, Slan+-Monocyte and Natural Killer Cell Counts Function as Blood Cell-Based Biomarkers for Predicting Responses to Immune Checkpoint Inhibitor Monotherapy in Non-Small Cell Lung Cancer Patients 101
Nitric oxide affects immune cells bioenergetics: long-term effects of nitric-oxide derivatives on leukaemic Jurkat cell metabolism 101
Immortalized myeloid suppressor cells trigger apoptosis in antigen-activated T lymphocytes. 100
Totale 14.056
Salva come PNG Salva come JPEG
Categoria #
all - tutte 89.022
article - articoli 79.638
book - libri 0
conference - conferenze 1.725
curatela - curatele 0
other - altro 1.428
patent - brevetti 1.642
selected - selezionate 0
volume - volumi 4.589
Totale 178.044
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.121 0 0 0 0 324 164 23 132 151 37 203 87
2021/20221.735 106 442 31 52 74 47 70 111 115 89 151 447
2022/20232.728 257 262 303 445 230 632 42 154 294 14 57 38
2023/20241.516 63 98 101 192 209 236 66 140 16 87 239 69
2024/20254.793 275 271 146 710 273 163 330 306 828 281 354 856
2025/20266.022 995 635 782 1.783 1.827 0 0 0 0 0 0 0
Totale 24.783